SecurityANW / Aegean Marine Petroleum Network, Inc. (Y0017S102)
Institutional Owners61
Institutional Shares18,064,536
Institutional Value$ 41,710,000 USD
Related Y0020QAA9 / Aegean Marine Petroleum Network, Inc. Bond

Institutional Stock Ownership and Shareholders

ANW / Aegean Marine Petroleum Network, Inc. Institutional Ownership

Aegean Marine Petroleum Network, Inc. (NYSE:ANW) has 61 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 18,064,536 shares. Largest shareholders include Senvest Management, LLC, Towle & Co, Schneider Capital Management Corp, Shah Capital Management, B. Riley Financial, Inc., Franklin Resources Inc, Arrowstreet Capital, Limited Partnership, Global X Management CO LLC, Arbiter Partners Capital Management LLC, and Foundry Partners, LLC.
Aegean Marine Petroleum Network, Inc. (NYSE:ANW) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/anw"><img src="https://images.fintel.io/us-anw-so.png" alt="ANW / Aegean Marine Petroleum Network, Inc. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-15 13F-HR STATE STREET CORP 56,657 46,242 -18.38 245 104 -57.55
2018-05-11 13F-HR Cutler Group LP 20,746 490 -97.64 89 1 -98.88
2018-05-15 13F-HR Capstone Financial Advisors, Inc. 40,000 70,000 75.00 172 158 -8.14
2018-05-04 13F-HR B. Riley Financial, Inc. 1,330,200 2,993
2018-05-08 13F-HR Advisornet Financial, Inc 1,200 1,200 0.00 5 3 -40.00
2018-05-15 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 0 1,958 0 4
2018-04-18 13F-HR Cordasco Financial Network 4,000 4,000 0.00 17 9 -47.06
2018-05-14 13F-HR AMERIPRISE FINANCIAL INC 1,315,330 0 -100.00 5,656 0 -100.00
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 74,433 65,483 -12.02 320 147 -54.06
2017-01-13 13F-HR MetLife Securities, Inc 107 535 400.00 1 5 400.00
2018-05-15 13F-HR Weiss Multi-Strategy Advisers LLC 0 89,408 0 201
2018-04-26 13F-HR SIMPLEX TRADING, LLC Put 26 26 0.00 1 3 200.00
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 10,097 0 -100.00 43 0 -100.00
2018-05-15 13F-HR CUSHING ASSET MANAGEMENT, LP 38,809 38,809 0.00 167 87 -47.90
2018-05-08 13F-HR TOWLE & CO 1,990,539 2,020,679 1.51 8,559 4,547 -46.87
2018-05-16 13F-HR Foundry Partners, LLC 532,771 468,210 -12.12 2,291 1,053 -54.04
2018-05-15 13F-HR Advisor Group, Inc. 595 595 0.00 3 1 -66.67
2018-05-14 13F-HR Royce & Associates LLC 1,250 0 -100.00 5 0 -100.00
2018-05-15 13F-HR UBS Group AG 1,800 1,334 -25.89 8 3 -62.50
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 51,241 45,650 -10.91 220 103 -53.18
2018-05-14 13F-HR ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 836,328 819,963 -1.96 3,596 1,845 -48.69
2018-05-15 13F-HR BARCLAYS PLC Call 200 2,700 1,250.00 1 6 500.00
2018-05-11 13F-HR SEI INVESTMENTS CO 137 0 -100.00 1 0 -100.00
2018-05-10 13F-HR FRANKLIN RESOURCES INC 930,000 930,000 0.00 3,999 2,093 -47.66
2018-05-14 13F-HR SCHNEIDER CAPITAL MANAGEMENT CORP 1,982,728 1,972,028 -0.54 8,526 4,437 -47.96
2018-05-09 13F-HR NORTHERN TRUST CORP 68,834 115,546 67.86 296 260 -12.16
2018-05-15 13F-HR WOLVERINE TRADING, LLC 13,133 0 -100.00 56 0 -100.00
2017-05-01 13F-HR Spot Trading L.L.C Put 0 1,000 0 12
2017-07-27 13F-HR Spot Trading L.l.c. Put 1,000 6
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 164 164 0.00 1 0 -100.00
2018-05-15 13F-HR WOLVERINE TRADING, LLC Put 11,400 0 -100.00 49 0 -100.00
2018-05-14 13F-HR Senvest Management, LLC 5,169,214 4,362,314 -15.61 22,228 9,815 -55.84
2018-05-15 13F-HR GV Financial Advisors 73 0
2018-04-26 13F-HR SIMPLEX TRADING, LLC 1,542 3,192 107.00 6 7 16.67
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 0 37,106 0 83
2018-05-14 13F-HR RAYMOND JAMES & ASSOCIATES 11,700 10,700 -8.55 50 24 -52.00
2017-07-27 13F-HR Spot Trading L.l.c. Call 42,600 249
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 23,837 28,240 18.47 103 64 -37.86
2018-05-11 13F-HR Cutler Group LP Call 0 1,600 0 0
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 0 4,971 0 11
2017-05-01 13F-HR Spot Trading L.L.C Call 0 35,000 0 422
2018-05-14 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 433,994 401,335 -7.53 1,866 903 -51.61
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Call 18,800 1,000 -94.68 81 2 -97.53
2018-05-11 13F-HR STIFEL FINANCIAL CORP 200,109 167,100 -16.50 847 352 -58.44
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Put 22,500 3,200 -85.78 97 7 -92.78
2018-05-15 13F-HR TWO SIGMA ADVISERS, LP 126,700 87,700 -30.78 545 197 -63.85
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 20,300 0 -100.00 87 0 -100.00
2018-05-14 13F-HR MORGAN STANLEY 48,884 77,687 58.92 210 174 -17.14
2018-05-09 13F-HR BlackRock Inc. 18,576 12,427 -33.10 80 28 -65.00
2018-05-14 13F-HR BB&T SECURITIES, LLC 139,327 29,559 -78.78 599 66 -88.98
2018-05-15 13F-HR RBF Capital, LLC 486,765 0 -100.00 2,093 0 -100.00
2018-05-11 13F-HR Mutual Advisors, Llc 103,690 233
2018-05-03 13F-HR Hodges Capital Management Inc. 73,500 115,000 56.46 316 259 -18.04
2018-05-15 13F-HR A.R.T. Advisors, LLC 20,033 124,257 520.26 86 279 224.42
2018-05-10 13F-HR FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. 11,200 26
2017-08-08 13F-HR Airain ltd 207,960 37,475 -81.98 2,506 219 -91.26
2018-05-04 13F-HR LSV ASSET MANAGEMENT 412,352 389,552 -5.53 1,773 876 -50.59
2018-05-15 13F-HR TWO SIGMA INVESTMENTS LLC 30,244 0 -100.00 130 0 -100.00
2018-05-15 13F-HR Invesco Ltd. 64,294 261,912 307.37 276 589 113.41
2017-02-10 13F-HR Pyrrho Capital Management, LP 0 121,000 0 1,228
2018-05-17 13F-HR Legal & General Group Plc 10,600 2,700 -74.53 46 6 -86.96
2018-05-14 13F-HR Virtu Financial LLC 11,085 14,980 35.14 48 34 -29.17
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 40,000 159,900 299.75 172 360 109.30
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 31,959 64,470 101.73 138 145 5.07
2018-05-14 13F-HR ASCEND CAPITAL, LLC 723,282 0 -100.00 3,110 0 -100.00
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 45,705 46,001 0.65 197 103 -47.72
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 185,642 66,735 -64.05 798 150 -81.20
2018-05-14 13F-HR FMR LLC / Fidelity 1,832,119 0 -100.00 7,878 0 -100.00
2018-05-15 13F-HR Cubist Systematic Strategies, LLC 0 28,424 0 64
2018-05-15 13F-HR BARCLAYS PLC Put 2,100 1,300 -38.10 9 3 -66.67
2018-05-02 13F-HR Global X Management CO LLC 659,251 752,218 14.10 2,835 1,692 -40.32
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. 0 6,254 0 14
2018-05-11 13F-HR GSA CAPITAL PARTNERS LLP 53,434 34,733 -35.00 230 78 -66.09
2018-05-14 13F-HR UBS ASSET MANAGEMENT AMERICAS INC 10,749 0 -100.00 46,221 0 -100.00
2018-05-11 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 1,003 1,003 0.00 4 2 -50.00
2018-05-03 13F-HR BRONFMAN E.L. ROTHSCHILD, L.P. 56 0 -100.00 0 0
2017-08-18 13F-HR WFG Advisors, LP 1 1 0.00 0 0
2018-05-14 13F-HR Laurion Capital Management LP 22,622 0 -100.00 97 0 -100.00
2018-05-15 13F-HR Arbiter Partners Capital Management LLC 1,778,132 638,565 -64.09 7,646 1,437 -81.21
2018-04-26 13F-HR SIMPLEX TRADING, LLC Call 4 97 2,325.00 0 4
2018-05-14 13F-HR/A CITADEL ADVISORS LLC Call 11,000 0 -100.00 47 0 -100.00
2017-04-21 13F-HR MAGEE THOMSON INVESTMENT PARTNERS LLC 86 1
2018-05-11 13F-HR MACQUARIE GROUP LTD 60,753 10,559 -82.62 261 24 -90.80
2018-05-15 13F-HR Lonestar Capital Management LLC 745,081 0 -100.00 3,204 0 -100.00
2018-05-11 13F-HR CITADEL ADVISORS LLC 65,483 147
2018-04-18 13F-HR SHAH CAPITAL MANAGEMENT 865,000 1,496,801 73.04 3,719 3,367 -9.46
2018-05-15 13F-HR BARCLAYS PLC 19,940 1,539 -92.28 86 3 -96.51
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 52,069 425,000 716.22 528 956 81.06

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Related News Stories

Emotions Get The Better Of Aegean Marine Petroleum Network

17h seekingalpha
Editor's note: Seeking Alpha is proud to welcome Nomis Research as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more » (2-0)

Aegean Marine: Did 'The Tiger' Leave Any Flesh On Its Prey?

2018-06-07 seekingalpha
The fate of common shareholders entirely dependent on the course of action taken by the activist investor group currently in charge. (89-9)

Carnival Cruises, Helios and Matheson Sink into Tuesday’s 52-Week Low Club

2018-06-05 247wallst
June 5, 2018: Here are four stocks trading with heavy volume among 78 equities making new 52-week lows in Tuesday’s session. On the NYSE advancers led decliners by about 1.39 to 1 and on the Nasdaq, advancers led decliners by about 1.73 to 1. (73-5)

After-hours buzz: SBUX, TWTR & more

2018-06-04 cnbc
Shares of Starbucks dropped 1.4 percent in extended trading, after Executive Chairman Howard Schultz announced he would be stepping down effective June 26. Schultz has played an essential role in the success of the coffee company, serving as CEO from 1987 through 2000 and again from 2008 through 2017, when he resigned from the position to be replaced by Kevin Johnson. Schultz's decision comes about a week after Starbucks closed for an afternoon for company-wide sensitivity training following the arrest of two black men in a Philadelphia Starbucks. (14-0)

BRIEF-Aegean Marine Petroleum Network Reaches Settlement Agreement With RBM Holdings

2018-05-02 reuters
* AEGEAN MARINE PETROLEUM NETWORK INC. REACHES SETTLEMENT AGREEMENT WITH RBM HOLDINGS LLC TO DISMISS SHAREHOLDER LITIGATION AND APPOINT TYLER BARON, RAYMOND BARTOSZEK AND DONALD MOORE TO THE BOARD (2-0)

CUSIP: Y0017S102